sBMYear=2021 and sBMMonth=8
sCurrentPeriodOrder=188 for period=August,2021
FertAid-Specials
This site is under development. Open QAPonline Open IVFDaily Open IVFCPD Open IVFBenchmark Open IVFLabOnline MID=188/188-August,2021   Logon Register
Use as part of your new staff development program.

Please contact us if you are interested in contributing to IVFCPD
IVFCPD is undergoing a major consolidation-pages may change frequently.
About
Support
Activities
Certificate


Key Points


CPD Modules CPD Topics CPD References CPD KeyWords My CPD
Key Words
abstinence
Accreditation
Acupuncture
advanced maternal age
advertising
AH
aneuploidy
Antioxidants
anxiety
artificial intelligence
biomarkers
Blastocyst morphology
blastocyst stage transfer
Calcium oscillations
Cancelled cycles
Cancer
Case Report
Catsper
Cell free DNA
cfDNA
CLBR
Compaction
Counselling
COVID-19
Cryostorage
Culture medium
cumulative live birth rate
delayed embryo development
depression
DNA methylation
Donor Sperm
Ejaculation
Elective oocyte cryopreservation
Elevated Progesterone
Embryo competency
embryo culture
embryo metabolism
Embryo Morphology
embryo secretome
embryo transfer
embryo-conditioned culture medium
Embryoids
Embryology
Endocrinology
Endometrial Thickness
endometriomas
Endometriosis
Euploidy,aneuploidy
Extracellular vesicles
female age
Fertilisation
fertility preservation
FET
Fetal anomalies
First-trimester
Follicular fluid
Freeze-all strategy
Frozen Embryos
Gender Selection
GM-CSF
GnRH agonist
Good-quality blastocyst
Guidelines
ICSI
icsi x ivf
implantation
Inteval to FET
IVF Laboratory
IVFChildren
Legal
Low Birthweight
luteinizing hormone
male fertility
Male Health
maternal age
Maximium oestradiol
Microbial contamination
microbiome
microfluidic
microfluidics
microRNA
miscarriage
Mitochondrial DNA (mtDNA)
morula
mosaicism
Multiple IVF cycles
Natural Cycles
niPGT-A
Noninvasive embryo assessment
non-male factor
Nursing
occupational health
OCP
OHSS
Oocyte
oocyte donation
Oocyte Freezing
oocyte maturation
oophorectomy
ovarian aging
ovulation induction
ovulation trigger
paternal age
PGT-A
platelet-rich autologous plasma (prp)
PLCz
Podcast
POI
Poor-quality embryos
POR
Pregnancy
Pregnancy Rate
PreTerm Birth
Pronuclear
Quality management
Research
risk Pregnancy
RNA
secretome
Self-correction
semen analysis
semen profile
Serum Progesterone
Sex Ratio
short abstinence
smooth endoplasmic reticulum
Social Egg Freezing
Spent culture medium
Sperm Cryopreservation
Sperm DNA fragmentation
Sperm Motility
Sperm Preparation
Sperm Selection
SSR
Stimulation
Stress
TESA
Time Lapse
Training
trophectoderm
Vitrification
Courses linked to KeyWord OHSS View in PubMed ID 465 Modules=2
ID Course      
GnRH Trigger with hCG supplementation+      
SSR- secondary sex ratio and OHSS+      
 
Web Links tagged to this keyword
       
8935 Ovarian Hyperstimulation Syndrome Is Associated with a High Secondary Sex Ratio in Fresh IVF Cycles with Cleavage-Stage Embryo Transfer: Results for a [2021]  
8933 GnRH agonist and hCG (dual trigger) versus hCG trigger for follicular maturation: a systematic review and meta-analysis of randomized trials [2021]  
8932 Low dose hCG supplementation in a Gn-RH-agonist trigger protocol is associated with worse pregnancy outcomes: a retrospective cohort study [2021]  
8897 ESHRE guideline: ovarian stimulation for IVF/ICSI† [2021]  
8578 A decision-making algorithm for performing or cancelling embryo transfer in patients at high risk for ovarian hyperstimulation syndrome after triggeri [2020]  
8331 Comparative study between agonist and antagonist protocols in PCOS patients undergoing ICSI: a cross-sectional study [2019]  
8106 Cumulative live birth rates following a ‘freeze-all’ strategy: a population-based study [2019]  
7934 Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes [2018]  
7890 Fresh versus frozen-thawed blastocyst transfer in high responders [2018]  
7857 Freezing of all embryos in in vitro fertilization is beneficial in high responders, but not intermediate and low responders: an analysis of 82,935 cyc [2018]  
7707 Ovarian response to controlled ovarian stimulation in women with different polycystic ovary syndrome phenotypes [2017]  
7671 A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled [2017]  
7384 PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian [2016]  
4438 Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles [2014]  
4350 Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials [2013]  
4226 Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction [2013]  
3984 Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG [2013]  
3982 Low-dose hCG supplementation after GnRH agonist triggering: don't be too quick on the trigger [2013]  
3955 Controlled ovarian hyperstimulation regimens: a review of the available evidence for clinical practice. On behalf of the British Fertility Society P&P [2013]  
2731 New Relief for Gynecological Disorders: Injectable Protein to Reverse Symptoms of Dangerous Conditions [2013]  
2578 Ovarian hyperstimulation syndrome and prophylactic human embryo cryopreservation: analysis of reproductive outcome following thawed ET [2012]  
2271 Freezing All Embryos in IVF With Transfer in a Later Non-Stimulated Cycle May Improve Outcome [2012]  
2172 Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment [2012]  
1965 Embryo freezing for preventing ovarian hyperstimulation syndrome [2012]  
1962 Cabergoline for preventing ovarian hyperstimulation syndrome [2012]  
1920 Prevention and Treatment of Ovarian Hyperstimulation Syndrome [2012]  
1884 Targeted gonadotrophin stimulation using the PIVET algorithm markedly reduces the risk of OHSS [2012]  
1847 Meta-analysis of GnRH antagonist protocols: do they reduce the risk of OHSS in PCOS? [2012]  
1810 Targeted gonadotrophin stimulation using the PIVET algorithm markedly reduces the risk of OHSS [2011]  
1804 Anti-Müllerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effec [2011]  
1771 Perspectives of mild cycle IVF: a qualitative study [2011]  
1729 Development of ovarian hyperstimulation syndrome: interrogation of key proteins and biological proce [2011]  
1551 Conventional ovarian stimulation no longer exists: the age of individualized ovarian stimulation [2011]  
1536 A single nucleotide polymorphism in BMP15 is associated with high response to controlled ovarian hyp [2011]  
1528 Safe Work Procedure - Liquid Nitrogen Safety [2011]  
1527 Safe Handling of Liquid Nitrogen [2011]  
919 Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome [2010]  
918 Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to preve [2010]  
916 CABERGO Reference List [2010]  
915 Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? [2010]  
 
Copyright IVFCPD Pty Ltd
Contact IVFCPD
Contact IVFCPD at Office@ivfcpd.com